Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment (Q43759857)

26 November 2017

Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment (English)

1 reference

26 November 2017

1 reference

parkinsonian syndrome

1 reference

Petroske E

1

1 reference

26 November 2017

Meredith GE

2

1 reference

26 November 2017

Callen S

3

1 reference

26 November 2017

Totterdell S

4

1 reference

26 November 2017

Lau YS

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

26 November 2017

1 reference

26 November 2017

106

1 reference

26 November 2017

3

1 reference

26 November 2017

589-601

1 reference

Parkinson's disease: pathophysiology

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Dopaminergic neurons intrinsic to the primate striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Kinetics of nigral degeneration in a chronic model of MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

The role of the environment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

The efficiency of systematic sampling in stereology and its prediction.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

1 reference

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Search for neurotoxins structurally related to 1-methyl-4-phenylpyridine (MPP+) in the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

The effect of diethyldithiocarbamate on the biodisposition of MPTP: an explanation for enhanced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Urinary excretion of MPTP and its primary metabolites in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Neurochemical and neurogenetic correlates of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Striatal dopamine deficiency in Parkinson's disease: role of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

The unbiased estimation of number and sizes of arbitrary particles using the disector

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Different rates of age-related loss for four murine monoaminergic neuronal populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Oxidative stress and genetics in the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900295-0

7 January 2021

10.1016/S0306-4522(01)00295-0

Identifiers

DOI

1 reference

26 November 2017

1 reference